Response to Comment on Zaccardi et al. Duration of Type 2 Diabetes and Incidence of Cancer: An Observational Study in England. Diabetes Care 2023;46:1923–1930

Author:

Zaccardi Francesco12ORCID,Ling Suping3,Brown Karen4,Davies Melanie25,Khunti Kamlesh126ORCID

Affiliation:

1. 1Leicester Real World Evidence Unit, Leicester Diabetes Research Centre, Leicester General Hospital, University of Leicester, Leicester, U.K.

2. 2Leicester Diabetes Research Centre, Leicester General Hospital, University of Leicester, Leicester, U.K.

3. 3Inequalities in Cancer Outcomes Network Group, Department of Noncommunicable Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, U.K.

4. 4Leicester Cancer Research Centre, Leicester Royal Infirmary, University of Leicester, Leicester, U.K.

5. 5National Institute for Health and Care Research, Leicester Biomedical Research Centre, University Hospitals of Leicester NHS Trust and University of Leicester, Leicester, U.K.

6. 6National Institute for Health and Care Research, Applied Research Collaboration East Midlands, University of Leicester, Leicester, U.K.

Funder

Hope Against Cancer

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3